ODNI Discloses U.S.-Funded Biomedical Labs in 30+ Countries: Gabbard Calls for Oversight and Transparency
The Director of National Intelligence, Tulsi Gabbard, revealed that the intelligence community has identified U.S.-funded biomedical laboratories operating in over 30 countries. This disclosure follows the release of new documents by Senator Rand Paul, alleging Dr. Anthony Fauci's ties to the intelligence community in debates over COVID-19 origins. Some of these labs have been involved in gain-of-function research, according to the ODNI.
Gabbard emphasized the importance of transparency and oversight in federal support for pathogen research overseas. She highlighted the presence of more than 120 U.S.-funded labs in various countries, including Ukraine, conducting research on hazardous pathogens. The ODNI is collaborating with federal partners to track these facilities and their activities.
The ODNI's efforts align with President Trump's directive to end federal funding for gain-of-function research globally. Gabbard raised concerns about the vulnerability of labs in Ukraine due to the ongoing conflict with Russia. The ODNI has expanded intelligence collection on overseas biological research facilities, focusing on ethical, financial, and security implications.
Amid a leadership transition at ODNI, Jay Clayton has been nominated as the next intelligence chief. His confirmation is crucial for advancing the extension of Section 702 of the Foreign Intelligence Surveillance Act. The appointment of Bill Pulte as interim head faced bipartisan criticism, contributing to the gridlock over surveillance authorities.
In conclusion, the ODNI's revelations about U.S.-funded labs and the transition in leadership underscore the importance of oversight and accountability in biological research. The ongoing efforts to enhance intelligence collection and address ethical concerns reflect a commitment to safeguarding national security interests.